Ongoing investigations into the drug are showcasing promising findings regarding weight management . Initially developed for treating type 2 diabetes , this GLP-1 receptor agonist has indicated impressive https://bookmarkick.com/story21524097/semaglutide-research-unlocking-emerging-weight-loss-opportunities